PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm
news

The International Society for Stem Cell Research brings researchers together in Melbourne

The conference is the world’s largest stem cell meeting and will attract more than 2,500 delegates from 60 countries, delivering around $13 million in economic impact...
Continue Reading →
news

Blood vessel-forming cells involved in aggressive brain tumour

Targeting cells involved in blood vessel formation could prevent the growth of the most common type of brain tumour. A type of highly malignant brain tumour contain...
Continue Reading →
news

WuXi Biologics Initiates Construction of a Integrated ADC Solution Center in China

This $20 million 6,000 square meter facility will be operational in 2019 and provide integrated solutions from concept to commercialization for biologics conjugates...
Continue Reading →
news

Emulate raises $36M to develop organ-on-chip tech

Boston, Mass.-based Emulate snapped up $36 million in funding from a Series C round led by Founders Fund and including ALS Investment Fund, SciFi VC, GlassWall Sy...
Continue Reading →
news

Nuance enters $58 M deal for non-opioid pain treatment in China

EXPAREL is a non-opioid option for achieving long-lasting pain control after surgery via infiltration into the surgical site or administration as an interscalene brac...
Continue Reading →
news

Alpha Biopharma announces series A financing

 AZD3759, AlphaBio's lead product, is a next-generation small molecule tyrosine kinase inhibitor (TKI). It is specifically designed to treat epidermal growth factor r...
Continue Reading →
news

PATH, SD Biosensor partner to advance malaria treatment

PATH is advancing a portfolio of novel rapid tests for G6PD deficiency that are low cost, simple to use, and meet specifications to improve treatment of patients with...
Continue Reading →
news

Esco Group acquires AT Medical UAB

 Esco Group to acquire AT Medical UAB, an Esco Ventures portfolio company, to accelerate development of the Esco life sciences ecosystem and delivery of innovative fe...
Continue Reading →
news

Moxidectin gets USFDA nod to treat River Blindness

 Medicines Development for Global Health (MDGH) and the World Health Organisation Special Programme for Research and Training in Tropical Diseases (TDR) have announce...
Continue Reading →
news

Suven Life Sciences gets patents in China and US

These patents add to the similar protections won in countries such as India, Korea, Singapore, Canada, Japan and Australia in the past. Suven Life Sciences said it ...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC